Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of ApexCharts and glyenzy — release velocity, themes, recent moves, and the top alternatives to consider.
Licensing settled, ApexCharts is back to changing what a chart can take as input.
ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.
Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.
glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.
ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.
The through-line now is input and arrangement rather than catalogue size. Charts increasingly accept the measurements a team actually has instead of pre-aggregated values, and the seams that let you hand a chart its own layout — plotOptions.unit.positions, the pluggable layout hook — are being filled in with kits rather than hard-coded options. The premium boundary has stopped moving; the free catalogue keeps growing around it.
Expect the raw-observation pattern to reach another chart type now that the bar pathway handles binning, and expect the remaining pluggable seams to get companion kits the way positions just did.
glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.
Two kinds of release alternate here. One is enzyme curation, a steady stream of rule corrections for the FUT, MAN1A and MGAT families and removals where an enzyme turned out to act only on glycolipids, which is the unglamorous accuracy work a rule-based inference engine lives on. The other is turning biosynthesis output into a first-class object: paths became networks, networks became typed with plotting support, and targets became a marked vertex attribute. The package moves in lockstep with its siblings, pinning glyrepr 0.13.0 and glymotif 0.17.0 as those refreshed their data and matching APIs, and the latest release already speaks glydraw 0.8.0's orientation values.
The paucimannose N-glycan support dropped in 0.7.0 is the obvious loose end, with users told to stay on 0.6.3, so a reinstated implementation is a plausible next move. Beyond that the virtual-step machinery is new enough that its heuristics, particularly the inferred step limits added in 0.8.1, should keep being tuned.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ApexCharts or glyenzy.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all ApexCharts alternatives → · See all glyenzy alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 6.3), with 3 editorial sparks in the last 30 days against 1. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 6.3), with 3 editorial sparks in the last 30 days against 1. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top ApexCharts alternatives in Analytics are ranked by recent ship velocity. Browse the "ApexCharts alternatives" section above for the current picks, or visit /alternatives/apexcharts for the full list with editorial commentary on each.
Top glyenzy alternatives in Analytics are ranked by recent ship velocity. Browse the "glyenzy alternatives" section above for the current picks, or visit /alternatives/glyenzy for the full list with editorial commentary on each.